Enthusiastic researcher with a keen interest in exploring complex scientific questions. Detail-oriented and committed to continuous learning, with a strong work ethic and a passion for discovery.
This research focuses on identifying genetically and epigenetically altered GPCRs, their associated ligands, and G-proteins in GBM using patient-derived datasets. It explores potential mechanisms of gene deregulation, including copy number variation, methylation, and miRNA regulation. Additionally, the study aims to validate the role of the upregulated gene GPR84 in GBM through in vitro and animal models by assessing the impact of its knockdown.
This study investigates the growth-inhibitory mechanism of the calcitonin (CT)/calcitonin receptor (CALCR) axis in glioblastoma (GBM) using a proteomic approach, Reverse Phase Protein Array (RPPA). Our findings reveal that CT effectively suppresses glioma progression by inhibiting key oncogenic effectors, YAP and TAZ, both in vitro and in vivo. Furthermore, molecular dynamics simulations of patient-derived CALCR mutations offer critical insights into structural and functional alterations that may contribute to receptor loss of function, potentially impairing its tumor-suppressive role.
Nationality: Indian
Cancer Stem Cells & Therapy Resistance, Targeted Therapy & Precision Medicine, Tumor Microenvironment & Immunotherapy.